Ellerson Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
6,667
+190
+3% +$91.2K 1.97% 22
2026
Q1
$3.18M Sell
6,477
-39
-0.6% -$21.2K 2.09% 22
2025
Q4
$3.78M Sell
6,516
-49
-0.7% -$27.7K 2.55% 15
2025
Q3
$3.18M Buy
6,565
+71
+1% +$33K 1.98% 23
2025
Q2
$2.63M Buy
6,494
+130
+2% +$54.4K 1.86% 25
2025
Q1
$3.17M Buy
6,364
+90
+1% +$48.7K 2.52% 19
2024
Q4
$3.26M Sell
6,274
-254
-4% -$140K 2.38% 19
2024
Q3
$4.04M Sell
6,528
-185
-3% -$110K 3.17% 10
2024
Q2
$3.71M Sell
6,713
-108
-2% -$61.9K 2.82% 12
2024
Q1
$3.96M Sell
6,821
-380
-5% -$213K 3.03% 11
2023
Q4
$3.82M Buy
7,201
+228
+3% +$110K 3.32% 12
2023
Q3
$3.53M Buy
6,973
+4
+0.1% +$2.13K 3.29% 11
2023
Q2
$3.64M Hold
6,969
3.46% 9
2023
Q1
$4.02M Sell
6,969
-8
-0.1% -$4.51K 4.35% 8
2022
Q4
$3.84M Buy
+6,977
New +$3.7M 4.07% 8

Other funds holding TMO

Ellerson Group's TMO Position: Q2 2026 in Review

Ellerson Group increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, buying an estimated $91.2K and bringing the position to 6,667 shares worth $3.34M. The position accounts for 1.97% of the portfolio, ranked #22.

Ellerson Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.04M in Q3 2024. 1,512 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ellerson Group held 6,667 shares of Thermo Fisher Scientific worth $3.34M as of Q2 2026.
  • Ellerson Group bought 190 Thermo Fisher Scientific shares in Q2 2026, an estimated $91.2K.
  • Thermo Fisher Scientific made up 1.97% of Ellerson Group's portfolio in Q2 2026, its #22 holding.
  • Ellerson Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Ellerson Group's Thermo Fisher Scientific position peaked at $4.04M in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ellerson Group's 13F filing for Q2 2026, filed 31 Jul 2026.